相关实验视频
Updated: Jun 7, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
降低2型糖尿病中的血糖-低血糖结局:一个随机临床试验
Elizabeth R Seaquist1, Lawrence S Phillips2, Alokananda Ghosh3
1Department of Medicine, Division of Diabetes and Endocrinology, University of Minnesota Medical School, Minneapolis, MN, United States of America.
在接受甲福明治疗的2型糖尿病 (T2DM) 患者中,添加glimepiride导致最多的低血糖症,而liraglutide和sitagliptin则是最少的. 格拉吉因显示低血糖的中间风险.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 低血糖是2型糖尿病 (T2DM) 管理中的一个重要并发症.
- 有限的比较数据存在于低血糖风险在常见的T2DM疗法,当添加到甲.
- 了解这些风险对于优化患者护理和治疗选择至关重要.
研究的目的:
- 为了比较T2DM患者中低血糖的发病率,用甲福林治疗,当添加四种常见类别的第二种药物时.
- 评估不同治疗方案中严重低血糖和低血糖症状的可能性.
主要方法:
- 一项随机对照试验,涉及5047名患有T2DM的参与者.
- 参与者被随机分配,在大约5年的时间里,将格拉素U100,格莱梅皮里德,利拉格卢提德或西塔格利普丁添加到甲胺治疗中.
- 低血糖症通过报告的事件,症状和测量葡萄糖水平来评估.
主要成果:
- 严重的低血糖发生在0.8% (glargine),1.3% (glimepiride),0.5% (liraglutide) 和0.3% (sitagliptin) 的参与者中.
- 报告的低血糖症状为54.2% (glargine),68.3% (glimepiride),32.4% (liraglutide) 和29.1% (sitagliptin) 的患者.
- 格利梅皮里德与严重低血糖和症状的最高率有关,而利拉格卢提德和西塔格利普丁显示最低.
结论:
- 在接受甲福明治疗的T2DM患者中,添加glimepiride带有低血糖的最高风险.
- 利拉格卢提德和西塔格利普丁与添加于甲胺时的低血糖风险最低.
- 与其他研究药物相比,Glargine U100对低血糖的风险概况中等.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
相关概念视频
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...